EULAR 2008 - Rheumatoid Arthritis : Clinical Aspects
The Annual European Congress of Rheumatology was held in Paris, France from June 11-14, 2008. This is the official meeting of the European League Against Rheumatism (EULAR). Full abstract reports may be can be found online by visiting the EULAR Congress website. While it is not possible to review all of the important findings from these meetings, some selected highlights are summarized. These highlights focus on Rheumatoid Arthritis. The highlights are summarized by Joan Bathon, M.D. and Jon Giles, M.D.
- OP-0040 – Jon Giles Drug-Free Remission after Treatment Discontinuation Following One Year of Methotrexate or Placebo Treatment in Undifferentiated Arthritis Patients
- OP-0137 – Jon Giles Does Inflammation and Immune-Suppressive Treatment Affect Survival from Cancer? A Nation-Wide Population Based Study on Cancer Survival in Patients with RA in Sweden 1999-2006
- OP-0138 – Jon Giles Risk of Active Tuberculosis among Biologic-Naïve RA Patients: Retrospective Cohort Study in a U.S. Claims Database
- OP-0139 – Jon Giles Influence of Gender on Assessments of Disease Activity and Function in Rheumatoid Arthritis in Relation to Radiologic Damage Over the First Five Years of Disease
- OP-0144 – Jon Giles Which Patients Stop Working Because of RA? Results from an Inception Cohort with 10 Yr Follow-up
